Amarin Corp Plc (AMRN)

[north40000]

JRoon, you better care. What makes you think the respective generic products of the 7 are any different from the Hikma product?  Can you demonstrate with evidence that any of the so-called generic V products differ from the Hikma product? That Hikma product, I'm sure you remember, has already been observed by the 3 judges( Lourie, J. Opinion ) of the CAFC to have no ANDA or sANDA approved by the FDA for a CVD indication and/or been shown by record evidence to be therapeutically equivalent to Branded product Vascepa. I'm also sure that the District Court Judges in Delaware or New Jersey will be made aware of those observations. Absent strong plausible evidence to the contrary from a generic company, those observations would seem to negate/settle the rights of any generic company to market, off-label, their respective products for CVD indications.

And then, "bless my soul", there is the continuing issue of the "fraud on the Nevada Court" that still lives/remains. No appellate Court--CAFC or Supreme Court-- has expressed an opinion on that issue, nor has any Federal agency like FTC, DOJ(FBI), SEC, ITC.  Marjac and I, with countless others, have explicated our views on that issue on many earlier occasions here.